by rss feed | Mar 17, 2022 | FDA, News Feeds, umbilical cord stem cells
The FDA has been busy with the COVID pandemic but it has many other things on its plate as well including cell therapies. Today I’m sharing some recent agency news and brief perspectives on it. FDA focus on clinic-related umbilical cord cell drug makers The...
by rss feed | Mar 2, 2022 | Liveyon, News Feeds, umbilical cord stem cells
Before starting the umbilical cord cell supplier and marketing firm Liveyon, John Kosolcharoen was involved in some alleged health care fraud. The feds brought a case against him related to prescription drugs. Older case coming to a head As Liveyon was having its...
by rss feed | Jan 5, 2021 | Camillo Ricordi, COVID-19, MSCs Mesenchymal stem stromal cells, News Feeds, Stem cells for COVID-19, umbilical cord stem cells
A new paper today in Stem Cells Translational Medicine on a small COVID-19 Phase 1/2a trial using an umbilical cord stem cell product reports a surprising degree of possible efficacy. What’s the scoop here and could there be some hype in the media about this new...
by rss feed | Jan 5, 2021 | Camillo Ricordi, COVID-19, MSCs Mesenchymal stem stromal cells, News Feeds, Stem cells for COVID-19, umbilical cord stem cells
A new paper today in Stem Cells Translational Medicine on a small COVID-19 Phase 1/2a trial using an umbilical cord stem cell product reports a surprising degree of possible efficacy. What’s the scoop here and could there be some hype in the media about this new...
by rss feed | Jan 5, 2021 | Camillo Ricordi, COVID-19, MSCs Mesenchymal stem stromal cells, News Feeds, Stem cells for COVID-19, umbilical cord stem cells
A new paper today in Stem Cells Translational Medicine on a small COVID-19 Phase 1/2a trial using an umbilical cord stem cell product reports a surprising degree of possible efficacy. What’s the scoop here and could there be some hype in the media about this new...